U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on China
NeutralFinancial Markets

U.S. drugmakers are warning the White House about potential chaos as President Trump considers new restrictions on China. Major pharmaceutical companies and billionaires connected to Trump are lobbying on opposite sides of the issue, highlighting the tension in the biotech sector.
Editor’s Note: This situation is significant as it reflects the ongoing struggle between U.S. and Chinese biotech industries. The outcome of these proposed measures could impact American companies and their ability to compete, as well as the broader relationship between the two countries.
— via World Pulse Now AI Editorial System